Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth

被引:39
作者
Baba, M
Hirai, S
Kawakami, S
Kishida, T
Sakai, N
Kaneko, S
Yao, M
Shuin, T
Kubota, Y
Hosaka, M
Ohno, S
机构
[1] Yokohama City Univ, Sch Med, Dept Biol Mol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan
[3] Kochi Med Sch, Dept Urol, Kochi 7838505, Japan
基金
日本学术振兴会;
关键词
VHL; tumor suppressor; contact inhibition; renal cell carcinoma; epithelial cells;
D O I
10.1038/sj.onc.1204397
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In spite of the general recognition of von Hippel-Lindau (VHL) as a tumor suppressor gene, the physiological and pathological importance of VHL protein in cell growth regulation and tumorigenesis remains unclear, Here we show that in normal human renal proximal tubule epithelial cells (RPTEC), the steady-state amount of VHL protein is strictly regulated by cell density. The cellular VHL content is more than 100-fold higher in dense cultures than in sparse cultures, The increase in VHL protein at high cell density was also observed for NIH3T3 fibroblasts, suggesting the generality of the phenomenon. The growth rates of renal cell carcinoma cells lacking an intact VHL gene and their derivatives with wild-type or mutant VHL expression vector do not differ significantly when they are growing in log-phase. Importantly, however, there is a difference when they reach confluency: cells lacking wild-type VHL grew continuously, while cells expressing exogenous VHL protein showed relatively limited cell growth. Using an ecdysone-inducible VHL expressing cell line, we also show that the growth inhibition at high cell density can be released by attenuating the VHL expression, Taken together, we propose that VHL protein functions as a growth suppressor at high cell density, and this might be the basis of the tumor suppressor function of VHL.
引用
收藏
页码:2727 / 2736
页数:10
相关论文
共 51 条
  • [1] Functional interaction of beta-catenin with the transcription factor LEF-1
    Behrens, J
    vonKries, JP
    Kuhl, M
    Bruhn, L
    Wedlich, D
    Grosschedl, R
    Birchmeier, W
    [J]. NATURE, 1996, 382 (6592) : 638 - 642
  • [2] Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity
    Blankenship, C
    Naglich, JG
    Whaley, JM
    Seizinger, B
    Kley, N
    [J]. ONCOGENE, 1999, 18 (08) : 1529 - 1535
  • [3] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
    Cockman, ME
    Masson, N
    Mole, DR
    Jaakkola, P
    Chang, GW
    Clifford, SC
    Maher, ER
    Pugh, CW
    Ratcliffe, PJ
    Maxwell, PH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) : 25733 - 25741
  • [4] Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
    Corless, CL
    Kibel, AS
    Iliopoulos, O
    Kaelin, WG
    [J]. HUMAN PATHOLOGY, 1997, 28 (04) : 459 - 464
  • [5] CUL-2 is required for the G1-to-S-phase transition and mitotic chromosome condensation in Caenorhabditis elegans
    Feng, H
    Zhong, WW
    Punkosdy, G
    Gu, SB
    Zhou, L
    Seabolt, EK
    Kipreos, ET
    [J]. NATURE CELL BIOLOGY, 1999, 1 (08) : 486 - 492
  • [6] SOMATIC MUTATIONS OF THE VON HIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE IN NONFAMILIAL CLEAR-CELL RENAL-CARCINOMA
    FOSTER, K
    PROWSE, A
    VANDENBERG, A
    FLEMING, S
    HULSBEEK, MMF
    CROSSEY, PA
    RICHARDS, FM
    CAIRNS, P
    AFFARA, NA
    FERGUSONSMITH, MA
    BUYS, CHCM
    MAHER, ER
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (12) : 2169 - 2173
  • [7] GAO JZ, 1995, CANCER RES, V55, P743
  • [8] MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA
    GNARRA, JR
    TORY, K
    WENG, Y
    SCHMIDT, L
    WEI, MH
    LI, H
    LATIF, F
    LIU, S
    CHEN, F
    DUH, FM
    LUBENSKY, I
    DUAN, DR
    FLORENCE, C
    POZZATTI, R
    WALTHER, MM
    BANDER, NH
    GROSSMAN, HB
    BRAUCH, H
    POMER, S
    BROOKS, JD
    ISAACS, WB
    LERMAN, MI
    ZBAR, B
    LINEHAN, WM
    [J]. NATURE GENETICS, 1994, 7 (01) : 85 - 90
  • [9] The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell
    Hart, M
    Concordet, JP
    Lassot, I
    Albert, I
    del los Santos, R
    Durand, H
    Perret, C
    Rubinfeld, B
    Margottin, F
    Benarous, R
    Polakis, P
    [J]. CURRENT BIOLOGY, 1999, 9 (04) : 207 - 210
  • [10] Identification of c-MYC as a target of the APC pathway
    He, TC
    Sparks, AB
    Rago, C
    Hermeking, H
    Zawel, L
    da Costa, LT
    Morin, PJ
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 1998, 281 (5382) : 1509 - 1512